Running head: CLOSTRIDIUM DIFFICILE 1

Similar documents
Clostridium difficile Colitis

Healthcare-associated Infections Annual Report December 2018

Community-Associated C. difficile Infection: Think Outside the Hospital. Maria Bye, MPH Epidemiologist May 1, 2018

Overview of C. difficile infections. Kurt B. Stevenson, MD MPH Professor Division of Infectious Diseases

Educational Module for Nursing Assistants in Long-term Care Facilities: Preventing and Managing Clostridium difficile Infections

Preventing Clostridium difficile Infection (CDI)

Clostridium Difficile Primer: Disease, Risk, & Mitigation

11/2/2015. Update on the Treatment of Clostridium difficile Infections. Disclosure. Objectives

Antimicrobial Stewardship

APPROVED PACKAGE INSERT. Each capsule contains clindamycin hydrochloride equivalent to 150 mg clindamycin base.

Policy for the Management of Clostridium Difficile

Healthcare-associated Infections Annual Report

Infection Control & Prevention

HOSPITAL-ACQUIRED INFECTION/MRSA EYERUSALEM KIFLE AND GIFT IMUETINYAN OMOBOGBE PNURSS15

Alfonso Torress-Cook, Dr.P.H. Director of Epidemiology/Patient Safety Pacific Hospital of Long Beach

Preventing Multi-Drug Resistant Organism (MDRO) Infections. For National Patient Safety Goal

Multi-Drug Resistant Organisms (MDRO)

ANTIMICROBIAL STEWARDSHIP: THE ROLE OF THE CLINICIAN SAM GUREVITZ PHARM D, CGP BUTLER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCES

Multidrug Resistant Organisms (MDROs) and Clostridium difficile (C. diff)

Anaerobic and microaerophilic gram-positive cocci Peptococcus species, Peptostreptococcus species, Microaerophilic streptococci

Physician Rating: ( 23 Votes ) Rate This Article:

Incidence of hospital-acquired Clostridium difficile infection in patients at risk

Clostridium difficile

Clostridium difficile Infection: An Update on the Current State of Prevention

Infection Control and Standard Precautions

Living with MRSA Learning how to control the spread of Methicillin-Resistant Staphylococcus Aureus (MRSA)

Hand washing, Asepsis, Precautions and Infection Control

Microbiology : antimicrobial drugs. Sheet 11. Ali abualhija

Antibiotics. Information for patients and carers Pharmacy Department. Patient information leaflet

The Epidemiology Of Clostridium Difficile Infections Among Oncology Patients

Your Guide to Managing. Multi Drug-resistant Organisms (MDROs)

8/17/2016 ABOUT US REDUCTION OF CLOSTRIDIUM DIFFICILE THROUGH THE USE OF AN ANTIMICROBIAL STEWARDSHIP PROGRAM

Healthcare-associated Infections Annual Report March 2015

Taking Action to Prevent and Manage Multidrug-resistant Organisms and C. difficile in the Nursing Home: Part 1 Reviewing the organisms

Antibiotic stewardship in long term care

Role of the nurse in diagnosing infection: The right sample, every time

Antimicrobial Stewardship in Continuing Care. Urinary Tract Infections Clinical Checklist

Multi-Drug Resistant Gram Negative Organisms POLICY REVIEW DATE EXTENDED Printed copies must not be considered the definitive version

Clostridium difficile Colitis

Overcoming Barriers to Antimicrobial Stewardship

Antimicrobial Stewardship 101

Infectious Disease in PA/LTC an Update. Karyn P. Leible, MD, CMD, FACP October 2015

Learning Objectives 6/1/18

Antimicrobial Stewardship in the Hospital Setting

2010 ARO/CDI Prevalence Survey. MRSA [ ] VRE [ ] Clostridium difficile [ ]

Horizontal vs Vertical Infection Control Strategies

Antibiotics in the trenches: An ER Doc s Perspective

MDRO s, Stewardship and Beyond. Linda R. Greene RN, MPS, CIC

: "INFECTION CONTROL: WHAT'S COMING IN 2017?" LISA THOMAS RN-BC STATE TRAINING COORDINATOR OFFICE OF LONG TERM CARE

11-ID-10. Committee: Infectious Disease. Title: Creation of a National Campylobacteriosis Case Definition

Nosocomial Antibiotic Resistant Organisms

Clinical Spectrum of Disease. Clinical Features. Risk Factors. Risk of CDAD According to Antibiotic Class. Fluoroquinolones as Risk Factor for CDAD

Today s Presenter. Objectives. Presented 12/15/16. Think Smart About Antibiotics: Striking a Balance Between Sepsis and CDI

Pharmacology Week 6 ANTIMICROBIAL AGENTS

Antimicrobial Stewardship in the Long Term Care and Outpatient Settings. Carlos Reyes Sacin, MD, AAHIVS

Optimizing Antimicrobial Stewardship Activities Based on Institutional Resources

What bugs are keeping YOU up at night?

Inappropriate Use of Antibiotics and Clostridium difficile Infection. Jocelyn Srigley, MD, FRCPC November 1, 2012

Overview of Infection Control and Prevention

Role of the general physician in the management of sepsis and antibiotic stewardship

Clinical Practice Standard

Antibiotic Stewardship in the LTC Setting

Treatment of septic peritonitis

Clostridium difficile Infection Prevention. Basics of Infection Prevention 2-Day Mini-Course 2012

Staph and MRSA Skin Infections Fact Sheet for Schools

Today s Agenda: 9/30/14

ANTIBIOTICS IN BLOODY DIARRHEA PROS AND CONS. 6th Danish Pediatric Infectious Diseases Symposium October 2012

Surveillance of Multi-Drug Resistant Organisms

What is Antibiotic Resistance. Antibiotic Resistance A Public Health Issue

LEPTOSPIROSIS. Understanding the risk to your dog

Similar to Penicillins: -Chemically. -Mechanism of action. -Toxicity.

Implementing Antibiotic Stewardship in Rural and Critical Access Hospitals

Clostridium difficile infection: The Present and the Future

USA Product Label CLINTABS TABLETS. Virbac. brand of clindamycin hydrochloride tablets. ANADA # , Approved by FDA DESCRIPTION

Glycopeptide Resistant Enterococci (GRE) Policy IC/292/10

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICATION PATIENT MEDICATION INFORMATION. Moxifloxacin tablets (as moxifloxacin hydrochloride)

New Zealand Consumer Medicine Information

Other Enterobacteriaceae

Understand the application of Antibiotic Stewardship regulations in LTC. Understand past barriers to antibiotic management concepts

11/22/2016. Antimicrobial Stewardship Update Disclosures. Outline. No conflicts of interest to disclose

Antimicrobial Update. Alison MacDonald Area Antimicrobial Pharmacist NHS Highland April 2018

Aminoglycosides. Spectrum includes many aerobic Gram-negative and some Gram-positive bacteria.

Oral and intestinal candidiasis. As adjuvant treatment with other local nystatin preparations to prevent reinfection.

Oral and intestinal candidiasis. As adjuvant treatment with other local nystatin preparations to prevent reinfection.

Enteric Clostridia. C. perfringens: general

Infection Comments First Line Agents Penicillin Allergy History of multiresistant. line treatment: persist for >7 days they may be

Host, Syndrome, Bug, Drug: Introducing 2 Frameworks to Approach Infectious Diseases Cases with an Antimicrobial Stewardship Focus

Science Read. 06 Feb. 2.8m-long tapeworm found in Singapore patient who had no symptoms

9/30/2016. Dr. Janell Mayer, Pharm.D., CGP, BCPS Dr. Lindsey Votaw, Pharm.D., CGP, BCPS

Enteric Clostridia 10/27/2011. C. perfringens: general. C. perfringens: Types & toxins. C. perfringens: Types & toxins

Can fluconazole treat c diff

ASCENSION TEXAS Antimicrobial Stewardship: Practical Implementation Strategies

مادة االدوية المرحلة الثالثة م. غدير حاتم محمد

Clostridium difficile: Review of Treatment & Prevention through Antimicrobial Stewardship

C Diff: The Latest Scope on

Guidelines for Antimicrobial treatment for treatment of confirmed infections adults

Appropriate Management of Common Pediatric Infections. Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases

Standing Orders for the Treatment of Outpatient Peritonitis

Carbapenemase-Producing Enterobacteriaceae (CPE)

Georgia State University. Georgia State University. Zirka Thompson. Spring

Transcription:

Running head: CLOSTRIDIUM DIFFICILE 1 Clostridium difficile Infection Christy Lee Fenton Mountainland Applied Technology College

CLOSTRIDIUM DIFFICILE 2 Clostridium difficile Infection Approximately 200,000 patients are infected with Clostridium difficile (C. difficile) each year. Over one billion dollars is spent each annually for treatment and diagnosis of C. difficile (Keske & Letizia, 2010). C. difficile is the number one cause of nosocomial diarrhea associated illness. It is a normal bacteria found in the intestines. Some antibiotics kill the natural flora in the intestines allowing C. difficile to multiply in large numbers very rapidly causing toxic spore forming gram positive anaerobic bacillus. Most patients acquire C. difficile during a hospital stay, usually while taking antibiotics. C. difficile can survive in the environment for several months and continue to infect anyone who comes in contact with the infected surface (Intermountain Healthcare, 2011; Hamm, 2000). Symptoms, Risk Factors and Diagnosis Some patients with C. difficile present asymptomatic, while more severe cases include colitis, pseudomembranous colitis and toxic megacolon, colonic preformation, sepsis and even death. Symptoms can occur within days of and weeks after the patient is prescribed antibiotics: watery and foul smelling stools, fever of 38 degree Celsius, abdominal pain, distension and cramping, weakness, leukocytosis, and dehydration (Keske & Letizia, 2010).. The majority of patients affected with C. difficile are aged 60 and over. This population typically makes frequent visits to the hospital, has compromised immunity, and is commonly on antibiotics. Half the onsets of C. difficile occur in a long term care facility even though the patient may have acquired the infection during a hospital stay (Keske & Letizia, 2010). The infection rate in older adults is up to ten times greater than younger populations. There are many other factors that contribute to the risk of the C. difficile infection: comorbid medical conditions, use of feeding tubes, and acid suppressant medications (Simor, 2010).

CLOSTRIDIUM DIFFICILE 3 A single stool sample can be tested using one of three most popular tests: cytotoxic assay, enzyme linked immunosorbent assay, or a stool culture. The stool culture is the least reliable diagnostic test. The cytotoxic assay is considered the gold standard in testing for C. difficile. It takes three days to receive results and is 94% to 100% accurate. The enzyme linked immunosorbent assay is the most common test. This test provides results in two to six hours and is 80 % to 90% accurate. If the patient does not present with diarrhea, testing is not recommended (Keske & Letizia, 2010). An endoscopy should only be performed in special cases. This test is more expensive and is only 50% accurate. It takes approximately two hours to complete and is an effective diagnosis of pseudomembranous colitis. The endoscopy is indicated when a patient has in ileus (Keske & Letizia, 2010). Treatment Most cases of C. difficile can be treated by simply removing the antibiotic therapy and providing adequate replacement fluids. Normal colonic bacteria flora will recover and the diarrhea will subside. This treatment is effective in 15 to 25% of the patients. Moderate cases require oral treatment with either metronidazole or vancomycin. Oral metronidazole is readily absorbed in the intestines and is well tolerated. Severe cases, which typically include the presentation of pseudomembranous colitis, severe diarrhea, treatment in a critical care unit, aged patient, fever of 38.3 degree Celsius and pronounced leukocytosis, should be treated with oral vancomycin. Vancomycin is not absorbed or metabolized in a notable amount. It is excreted in the stool and is therefore an ideal treatment. Patients with an ileus or megacolon should be treated with metronidazole intravenously. Possible side effects for treatment with metronidazole include: nausea, vomiting, headache, dizziness, abdominal pain, diarrhea, rashes and

CLOSTRIDIUM DIFFICILE 4 neutropenia. Most cases of C. difficile improve in three to six days. Treatment may continue for 10 to 14 days. Prolonged and tapering doses of oral vancomycin have been reported to be effective in preventing subsequent occurrences (Simor, 2010; Hamm, 2000). Prevention and Interventions Patients being treated with antibiotic therapy, especially in a hospital setting, should be suspect for diagnosis of C. difficile. Patients should be tested as soon as symptoms occur. Patients should be placed in a private room with their own supplies and restroom. Healthcare professionals should use contact precautions: wash hands with soap and water, don gloves and a gown when in direct contact with patient or patient excretions (Simor, 2010). Hand hygiene, utilizing soap and water verses alcohol based products is the highest priority for the patient, the healthcare providers, family and visitors. Hand hygiene combined with gloves is more effective in preventing the carriage of C. difficile and interrupting the transmission. Effective environmental cleaning is essential, during the patient s hospital stay and after the patient is discharged. Most healthcare facilities are taking a bundled approach to the prevention of C. difficile: infection control, antimicrobial management, hand hygiene, implementing barrier precautions and reduced use of antibiotics: cephalosporins, clindamycin and flouroquinolone (Simor, 2010). Most often, the diarrhea will have subsided before the patient goes home. Home intervention should continue: including hand hygiene, completing medication prescribed and continued hydration. Avoid unnecessary use of antibiotics, especially for the treatment of common colds and viruses. If symptoms persist or represent call your doctor immediately (Intermountain Healthcare, 2011).

CLOSTRIDIUM DIFFICILE 5 References Hamm, L. (2000, June). Clostridium difficile. Medscape, 6(6). Retrieved from http://the.medscape.com/viewarticle/410904 Intermountain Healthcare (2011). Lets talk about Clostridium difficile. Salt Lake City, UT: Intermountain Primary Children s Medical Center. 1-3. Keske, L. A., & Letizia, M. J. (2010, November) Clostridium difficile infection: Essential information for nurses. Medsurg Nursing, 19(6). Retrieved from http://www. medscape.com/medline/abstract/21337989 Simior, A. E. (2010), Diagnosis, management, and prevention of Clostridium difficile infection in long-term care facilities: A review. The American Geriatrics Society, 58, 1556-1564. doi: 10.1111/j.1532-5415.2010.02958.x

CLOSTRIDIUM DIFFICILE 6 Jenn, I used the following to determine how to show my references: 1. Hamm (2000): This is a journal article from an online magazine: MedScape. Note article in the URL. I referred to page 200 of the APA book, item #8. 2. Intermountain (2011): Per Jenn in class. 3. Keske (2010): This is a journal article from an online magazine: MEDSURG Nursing. I referred to page 200 of the APA book, item #8. 4. Simor (2010): States it is a journal and it has a DOI. I referred to page 198 in the APA book, item 2. Other Relevant Information: I used C. difficile as the abbreviation of Clostridium difficile. I also bracketed it after the proper use. The articles and CDC web site used it this way. I reviewed page 106-108, 4.25, for my conclusion. The C in Clostridium is capitalized in all articles, on the CDC web site. This particular word is puzzling to me. I referred to page 102 of the APA book, 4.16. It states to capitalize proper names and adjectives and words used as proper nouns. I checked out the Merriam Webster dictionary and this is what I found in: Taxonomic names are used in definitions in this dictionary to provide precise identifications through which defined terms may be pursued in technical writings. Because of their specialized nature, taxonomic names as such are not included as dictionary entries. However, many common names entered in this dictionary have been derived directly from genus names and other taxonomic names, often with little or no modification. In written text it is particularly important to distinguish between a common name and the taxonomic name from which it is derived. In contrast to the styling rules for taxonomic names (discussed below), common names (as "clostridium," "drosophila," and "enterovirus") are not usually capitalized or italicized, and common names derived from genus names can have a plural form even though genus names themselves are never pluralized. I am not sure how you want this or what the best interpretation is. Since three of my articles are

CLOSTRIDIUM DIFFICILE 7 journals and two are of recent date, 2010, I am opting to leave it capitalized. I will wait for your feedback. I also capitalized the C in Celsius per Merriam Webster dictionary. I capitalized the C in Clostridium in the body of the reference information as Christie showed me that is how you approved it in her last paper. Hope I covered everything correctly. Thanks! Christy Lee Fenton